NFE2L2 and pulmonary arterial hypertension: Furthermore, another promising Nrf2 inducer is 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid-methyl ester, which is a candidate for treating pulmonary hypertension and for chronic kidney disease associated with type 2 diabetes13.